Impact of Hematuria Risk-Stratification Guidelines on CT Urography Detection of Upper Urinary Tract Malignancy.

Objectives and Hypothesis: CT urography (CTU) is a preferred diagnostic modality in hematuria evaluation and has the highest sensitivity and specificity for upper urinary tract malignancy, including renal cell carcinoma and upper tract urothelial carcinoma. Recent guidelines offer differing approach...

Descripción completa

Detalles Bibliográficos
Publicado en:Applied Radiology Vol. 55; no. 1; pp. 21 - 30
Autores principales: Rumball, Ian, Arenz, Andrea A., Bennie, Barbara A., Riherd, Jody
Formato: practice guidelines research tables/charts Journal Article
Publicado: Anderson Publishing Ltd. Jan2026
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=191474458&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 191474458
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        01609963
        45A
      jtl: Applied Radiology
      issn: 01609963
      maglogo: N
    pubinfo:
      dt: Jan2026
      vid: 55
      iid: 1
      pid: 6733
      pub: Anderson Publishing Ltd.
      place: Scotch Plains, New Jersey
    artinfo:
      ui:
        191474458
        191474458
        191474458
        10.37549/AR-D-25-0148
        191474458
      ppf: 21
      ppct: 9
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Impact of Hematuria Risk-Stratification Guidelines on CT Urography Detection of Upper Urinary Tract Malignancy.
      aug:
        au:
          Rumball, Ian
          Arenz, Andrea A.
          Bennie, Barbara A.
          Riherd, Jody
        affil: Department of Radiology, Medical College of Wisconsin, Milwaukee, Wisconsin
      sug:
        subj:
          Urologic Neoplasms Diagnosis
          Hematuria Risk Factors
          Risk Assessment
          Urography Methods
          Tomography, X-Ray Computed
          Sensitivity and Specificity
          Carcinoma, Renal Cell Diagnosis
          Practice Guidelines
          Human
          United States
          Male
          Female
          Middle Age
          Aged
          Retrospective Design
          Record Review
          Nonexperimental Studies
          Descriptive Statistics
          Pearson's Correlation Coefficient
          Chi Square Test
          Fisher's Exact Test
          Post Hoc Analysis
          Data Analysis Software
          Cancer Patients
          Early Detection of Cancer
          Decision Making, Clinical
          Reference Books
          Radiologic Health
          Urography Utilization
          Radiation Injuries
          Health Care Costs
          False Positive Results
          Middle Aged: 45-64 years
          Aged: 65+ years
          Male
          Female
      ab: Objectives and Hypothesis: CT urography (CTU) is a preferred diagnostic modality in hematuria evaluation and has the highest sensitivity and specificity for upper urinary tract malignancy, including renal cell carcinoma and upper tract urothelial carcinoma. Recent guidelines offer differing approaches to risk stratification of patients with hematuria, which may affect malignancy detection and CTU use. We hypothesize that among CTUs obtained for hematuria, there will be increased diagnostic yield for upper tract malignancy for imaging obtained in accordance with recent risk-stratification guidelines. Materials and Methods: This retrospective observational study assessed patients who underwent primary CTU for hematuria at a rural health system between January 1, 2021, and July 31, 2023. Cases were divided into microscopic and gross hematuria, and risk-stratified according to the 2020 American Urologic Association (AUA), 2023 Dutch Urological Association (DUA), and 2025 AUA guidelines. CTU, cystoscopy, and pathology reports were reviewed. Prevalence and diagnostic yield between subgroups were compared with appropriate statistical analyses. Results: Among 969 patients (mean age 65 years), CTU detected pathologically confirmed upper tract malignancy in 28 (2.9%). Diagnostic yield was not significantly higher among CTUs performed in concordance with the 2020 AUA (3.2% vs 0%; P = .4), 2023 DUA (3.4% vs 2.2%; P = .4), and 2025 AUA (3.4% vs 0%; P = .1) guidelines. Of the 274 patients for whom CTU was not recommended by the DUA guidelines, 6 had pathologically confirmed upper tract malignancy, contrasted with none for the AUA 2020 and 2025 guidelines. Conclusions: Application of risk-stratification guidelines did not significantly improve diagnostic yield of CTU detection for upper tract malignancy among patients presenting with hematuria. Despite this, risk-stratification approaches are likely warranted given poor yield in low-risk populations. Guidelines differed in the rate of recommended CTU use and the number of cases of potentially nonimaged upper tract malignancies.
      pubtype: Academic Journal
      doctype:
        practice guidelines
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N